ClearPoint Neuro, Inc. (CLPT) stock declined over -2.71%, trading at $17.92 on NASDAQ, down from the previous close of $18.42. The stock opened at $18.51, fluctuating between $17.79 and $18.89 in the recent session.
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Employees | 107 |
Beta | 1.11 |
Sales or Revenue | $23.96M |
5Y Sales Change% | 0.447% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Devices |
ClearPoint Neuro, Inc. (NASDAQ: CLPT) stock price is $17.92 in the last trading session. During the trading session, CLPT stock reached the peak price of $18.89 while $17.79 was the lowest point it dropped to. The percentage change in CLPT stock occurred in the recent session was -2.71% while the dollar amount for the price change in CLPT stock was -$0.50.
The NASDAQ listed CLPT is part of Medical - Devices industry that operates in the broader Healthcare sector. ClearPoint Neuro, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Joseph Michael Burnett
Pres, Chief Executive Officer & Director
Ms. Ellisa Cholapranee
Gen. Counsel & Sec.
Mr. Mazin Sabra
Chief Operating Officer
Mr. Danilo D'Alessandro
Chief Financial Officer
Ms. Jacqueline Keller
Vice President of Marketing
Mr. Jeremy Stigall
Executive Vice President and GM of Biologics & Drug Delivery
CLPT's closing price is 250.69% higher than its 52-week low of $5.11 where as its distance from 52-week high of $19.00 is -5.68%.
Number of CLPT employees currently stands at 107.
Official Website of CLPT is: https://www.clearpointneuro.com
CLPT could be contacted at phone 888 287 9109 and can also be accessed through its website. CLPT operates from 120 S. Sierra Avenue, Solana Beach, CA 92075, United States.
CLPT stock volume for the day was 247.2K shares. The average number of CLPT shares traded daily for last 3 months was 236.51K.
The market value of CLPT currently stands at $494.32M with its latest stock price at $17.92 and 27.58M of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com